Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Director | January 26, 2026 | January 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 26, 2026 · Filed January 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 231,487 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Grant · Acquired 30,453 · Balance 231,487 F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 20,000 |
Reported balance
Holding disclosure · report date 2026-01-26 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 20,000 F2: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectSpouse as Guardian for Grandchildren | 10,000 |
Reported balance
Holding disclosure · report date 2026-01-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 10,000 F2: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.
F2: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008473 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,487 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| October 23, 2025 Filed Oct 27, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 25,000 | $11.02 | $275,500.00 |
DisclosureSEC source: 0001213900-25-102764 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,034 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.01 to $11.03, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 21:07 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-005671 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,034 F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date. Read SEC document |
| March 05, 2024 Filed Mar 20, 2024 16:26 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0000899140-24-000324 · form4.xml · derivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-03-05 F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| May 18, 2023 Filed May 19, 2023 16:02 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 6,000 | $4.54 | $27,258.00 |
DisclosureSEC source: 0000929638-23-001538 · form4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,034 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.53 to $4.55, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 19:00 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-23-003553 · ownership.xml · derivative · entry 4 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-01-14 F2 · derivative.exercise_date: These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| May 17, 2022 Filed May 18, 2022 17:21 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 5,000 | $3.78 | $18,900.00 |
DisclosureSEC source: 0001213900-22-027983 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,034 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.79, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 16:16 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001213900-22-008949 · doc4.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-02-22 F7 · derivative.exercise_date: These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:08 UTC | CorMedix Inc. CRMD · Entity 5280 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-067924 · doc4.xml · nonDerivative · entry 4 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,034 F7 · kind: The reporting person gifted these shares of common stock to his family members. The reporting person is not deemed to be the beneficial owner of these shares. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:08 UTC | CorMedix Inc. CRMD · Entity 5280 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-067924 · doc4.xml · nonDerivative · entry 3 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,034 F7 · kind: The reporting person gifted these shares of common stock to his family members. The reporting person is not deemed to be the beneficial owner of these shares. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:08 UTC | CorMedix Inc. CRMD · Entity 5280 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-067924 · doc4.xml · nonDerivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,034 F7 · kind: The reporting person gifted these shares of common stock to his family members. The reporting person is not deemed to be the beneficial owner of these shares. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:08 UTC | CorMedix Inc. CRMD · Entity 5280 | GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-067924 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,034 F7 · kind: The reporting person gifted these shares of common stock to his family members. The reporting person is not deemed to be the beneficial owner of these shares. Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 16:45 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 10,000 | $5.14 | $51,400.00 |
DisclosureSEC source: 0001213900-21-060879 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,034 Read SEC document |
| May 17, 2021 Filed May 19, 2021 17:40 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 15,000 | $6.03 | $90,477.00 |
DisclosureSEC source: 0001213900-21-027991 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,034 F1 · price: This transaction was executed in multiple trades at prices ranging from $5.98 to $6.09. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:21 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002064 · doc4.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 08:25 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 15,300 | $4.27 | $65,358.54 |
DisclosureSEC source: 0001213900-20-025324 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,034 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.25 to $4.28. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 19:02 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 15,000 | $4.08 | $61,159.50 |
DisclosureSEC source: 0001213900-20-022562 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,734 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.04 to $4.0899. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 15, 2020 Filed May 18, 2020 16:20 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 10,000 | $3.85 | $38,500.00 |
DisclosureSEC source: 0001213900-20-012822 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,734 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.8199 to $3.88. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:46 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004978 · doc4.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 17:14 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 5,000 | $6.81 | $34,050.00 |
DisclosureSEC source: 0001213900-19-019413 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,734 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $6.74 to a high of $6.85 per share. Read SEC document |
| August 16, 2019 Filed Aug 16, 2019 16:08 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 6,000 | $8.06 | $48,360.00 |
DisclosureSEC source: 0001213900-19-016170 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,734 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $8.04 to a high of $8.07 per share. Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 16:06 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 20,000 | $1.65 | $33,000.00 |
DisclosureSEC source: 0001654954-19-003085 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,666 Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 75,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · derivative · entry 5 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-01-10 F2 · derivative.exercise_date: These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · nonDerivative · entry 4 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,666 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · nonDerivative · entry 3 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,666 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · nonDerivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,666 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,666 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 16:01 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 50,000 | $1.47 | $73,300.00 |
DisclosureSEC source: 0001654954-18-014003 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,166 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $1.4350 to a high of $1.47 per share. Read SEC document |
| November 23, 2018 Filed Nov 27, 2018 16:19 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 50,000 | $1.30 | $64,795.00 |
DisclosureSEC source: 0001654954-18-013254 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,166 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $1.2775 to a high of $1.30 per share. Read SEC document |
| November 06, 2018 Filed Nov 27, 2018 16:08 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-013249 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These Restricted Stock Units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested in full on the first anniversary of the date of grant, which was November 6, 2018. F1 · derivative.expiration_date: These Restricted Stock Units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested in full on the first anniversary of the date of grant, which was November 6, 2018. Read SEC document |
| November 06, 2018 Filed Nov 27, 2018 16:08 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-013249 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These Restricted Stock Units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested in full on the first anniversary of the date of grant, which was November 6, 2018. Read SEC document |
| October 01, 2018 Filed Oct 1, 2018 16:02 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010714 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_date: These restricted stock units were granted on 10/01/2018 for service on the Company's Strategic Finance Committee. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest monthly and will vest in full on the first anniversary of the date of grant, subject to continued service on the board. F1 · derivative.expiration_date: These restricted stock units were granted on 10/01/2018 for service on the Company's Strategic Finance Committee. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest monthly and will vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| October 01, 2018 Filed Nov 27, 2018 16:09 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013250 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,166 F1 · price: These shares consist of restricted stock units granted on 10/1/2018. The restricted stock units vest monthly and will vest in full on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. Read SEC document |
| February 21, 2018 Filed Mar 22, 2018 16:03 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-002935 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested in full on the first anniversary of the date of grant, which was February 21, 2018. F1 · derivative.expiration_date: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested in full on the first anniversary of the date of grant, which was February 21, 2018. Read SEC document |
| February 21, 2018 Filed Mar 22, 2018 16:03 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-002935 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested in full on the first anniversary of the date of grant, which was February 21, 2018. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:04 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001719 · section16.xml · derivative · entry 4 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:04 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001719 · section16.xml · derivative · entry 3 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:04 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001719 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: These options were granted on 2/16/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:23 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common STock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-013417 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F2 · derivative.exercise_date: These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:23 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 22,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013417 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,166 F1 · price: These shares consist of restricted stock units granted on 2/16/2018. The restricted stock units vest monthly and will vest in full on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 16:29 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 104,166 | $0.48 | $49,999.68 |
DisclosureSEC source: 0001654954-17-011663 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,166 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| November 06, 2017 Filed Dec 15, 2017 16:01 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-17-011696 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of November 6, 2017, subject to continued service on the board. F1 · derivative.exercise_date: The restricted stock units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of November 6, 2017, subject to continued service on the board. F1 · derivative.expiration_date: The restricted stock units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of November 6, 2017, subject to continued service on the board. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 07:43 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 80,000 | $0.40 | $31,840.00 |
DisclosureSEC source: 0001654954-17-007775 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.380 to $0.410. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 16:02 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 50,000 | $0.35 | $17,400.00 |
DisclosureSEC source: 0001654954-17-007678 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.3344 to $0.36. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:08 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 30,000 | $0.49 | $14,820.00 |
DisclosureSEC source: 0001354488-17-000517 · issuerdirect_section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.472 to $0.500. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:06 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000310 · issuerdirect_section16.xml · derivative · entry 3 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:06 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001354488-17-000310 · issuerdirect_section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.